Clinical Trial Update: Furoscix in Heart Failure Patients With Diuretic Resistance [Phase 2]

View source ↗

Summary

Phase 2 trial of Furoscix (furosemide) in heart failure patients with diuretic resistance has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Furosix (furosemide)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2025-07-16